Perioperative use of esmolol

Area of Science:

• Anesthesiology
• Cardiovascular Pharmacology
• Surgical Stress Response

Background:

• Surgical stimuli cause adrenergic responses, increasing heart rate and blood pressure.
• These responses pose risks for patients with ischemic heart disease due to increased myocardial oxygen demand.
• Long-acting beta blockers have unpredictable effects and difficult-to-reverse adverse events.

Purpose of the Study:

• To evaluate the efficacy and safety of esmolol in managing perioperative adrenergic responses.
• To highlight esmolol's advantages over traditional long-acting beta blockers.
• To present esmolol as an alternative to deepening anesthesia for managing surgical stress.

Main Methods:

• Clinical studies were conducted during the perioperative period.
• Esmolol's safety and efficacy were assessed in patients undergoing various surgeries.
• Pharmacokinetic properties, including rapid onset and elimination half-life, were considered.

Main Results:

• Esmolol is safe and effective in patients across ASA classifications I-IV.
• Esmolol demonstrated efficacy in patients undergoing carotid endarterectomy and coronary artery bypass surgery.
• The drug successfully blunts transient, intense adrenergic responses to surgical stress.

Conclusions:

• Esmolol offers significant advantages in perioperative hypertension and tachycardia management.
• Its pharmacokinetic profile makes it ideal for managing acute surgical stress responses.
• Esmolol provides a safer alternative to long-acting beta blockers and increased anesthetic depth.